π Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
CreditAccess Grameen Secures USD 75 Million Syndicated Social Loan Facility
CreditAccess Grameen (CA Grameen) has successfully raised USD 75 million through a syndicated social loan facility, with HSBC acting as the sole lead arranger. This fundraise is part of a larger strategy that has seen the company secure over USD 300 million in global commitments during FY 2025-26. The company has significantly diversified its liability franchise, increasing its share of foreign borrowings from 9% to 24% over the last five years. These funds, with a 3-5 year tenure, will improve the company's asset-liability management (ALM) and support its microfinance lending operations.
Key Highlights
Secured USD 75 million syndicated social loan facility from a diverse group of international banks including HSBC, Doha Bank, and Bank of China.
Total foreign commitments for FY 2025-26 now exceed USD 300 million, strengthening the liability franchise.
Share of foreign borrowings in the total liability mix has grown from 9% to 24% over the past five years.
Foreign sources accounted for over 15% of the company's total borrowing requirements in FY 2025-26.
The 3-5 year tenure of these borrowings significantly enhances the company's ALM profile and liquidity position.
πΌ Action for Investors
Investors should view this as a positive development reflecting the company's strong credit profile and ability to access low-cost international capital. The diversification of funding sources and improved ALM profile are likely to support stable margins and long-term growth.
CreditAccess Grameen Promoter Explores Stake Sale to Provide Exit for Long-Term Investors
CreditAccess Grameen's promoter, CreditAccess India B.V., has announced it is exploring the possibility of identifying new investors. This move is intended to provide an exit opportunity for the promoter's own long-term investors, as reported in The Economic Times on February 09, 2026. While the company has not confirmed a specific deal, this indicates a potential significant shift in the shareholding structure. Investors should note that no material development has been finalized yet, but the search for new capital partners is officially underway.
Key Highlights
Promoter CreditAccess India B.V. is seeking new investors to facilitate an exit for existing backers.
The announcement follows a news report in The Economic Times dated February 09, 2026.
The company clarified the situation under Regulation 30 of SEBI Listing Obligations.
No specific transaction size, valuation, or timeline has been disclosed at this stage.
The company has committed to making further disclosures as material developments occur.
πΌ Action for Investors
Investors should monitor the stock closely as a change in promoter backing or a large secondary market transaction can lead to price volatility. Wait for clarity on the profile of the incoming investors and the potential impact on management continuity.
CreditAccess Grameen Denies Axis Bank Buyout Rumors as Speculative
CreditAccess Grameen Limited has issued a formal clarification to the stock exchanges regarding media reports suggesting Axis Bank is in the lead to acquire the company. The management has labeled these reports as "baseless and speculative," stating that no decisions have been made regarding a potential sale by promoters. While the company acknowledged that promoters periodically evaluate liquidity options, they confirmed there is no material information currently requiring disclosure under Regulation 30. This response follows a sharp movement in trading activity triggered by the acquisition rumors.
Key Highlights
Company officially denies reports of Axis Bank leading a buyout, calling them speculative.
Promoters confirm no decision has been reached regarding any stake sale or investment by the named bank.
Management states no undisclosed material information exists under SEBI LODR Regulation 30.
The company maintains that promoters periodically evaluate liquidity options for shareholders as a standard practice.
πΌ Action for Investors
Investors should remain cautious and avoid trading based solely on acquisition rumors which the company has officially denied. Focus on the company's core microfinance performance while monitoring for any official updates regarding promoter stake changes.
CreditAccess Grameen Q3 FY26: PAT Doubles QoQ to βΉ252 Cr as Asset Quality Normalizes
CreditAccess Grameen reported a strong recovery in Q3 FY26, with PAT doubling sequentially to INR 252 crore and NIM expanding by 60 bps to 13.9%. Asset quality showed significant improvement as monthly PAR 15+ accretion dropped sharply to 18 bps in December from 47 bps in September. The company maintained robust growth with disbursements of INR 5,767 crore and a 13.4% YoY increase in Net Interest Income. Management highlighted the successful implementation of MFIN guardrails, which significantly reduced exposure to highly indebted borrowers.
Key Highlights
PAT doubled QoQ to INR 252 crore, translating to an ROA of 3.5% and ROE of 13.8%.
Asset quality improved significantly with X bucket collection efficiency at 99.71% and PAR 15+ accretion falling to 18 bps in December.
Net Interest Margin (NIM) expanded by 60 bps QoQ to 13.9%, aided by a 26 bps reduction in average cost of borrowings to 9.4%.
Retail finance portfolio share increased to 14.1% of AUM, up from 11.1% in the previous quarter.
Exposure to borrowers with more than 3 lenders dropped to 4.9% in December 2025 from 25.3% in August 2024.
πΌ Action for Investors
Investors should note the sharp decline in PAR accretion and the normalization of the Karnataka market as strong indicators of a turnaround. The company's ability to lower borrowing costs and diversify into retail finance provides a positive outlook for long-term profitability.
CreditAccess Grameen Q3 FY26 PAT Doubles QoQ to βΉ252 Cr; 9.12 Lakh ESOPs Granted
CreditAccess Grameen reported a significant sequential recovery with Net Profit (PAT) doubling to βΉ252.09 crore in Q3 FY26, up from βΉ125.81 crore in Q2 FY26. While year-on-year PAT declined by 42.5% from βΉ438.09 crore, the sharp reduction in impairment costs from βΉ525.67 crore in the previous quarter to βΉ342.57 crore indicates improving asset quality. Total revenue from operations grew 8% YoY to βΉ1,490.41 crore. Additionally, the board approved the grant of 9,12,500 stock options to employees at an exercise price of βΉ1,344.97.
Key Highlights
Net Profit (PAT) surged 100.4% quarter-on-quarter to βΉ252.09 crore.
Impairment on financial instruments (provisions) decreased by 34.8% QoQ to βΉ342.57 crore.
Total revenue from operations stood at βΉ1,490.41 crore, an 8% increase over Q3 FY25.
Board approved 9,12,500 ESOPs at an exercise price of βΉ1,344.97 per share.
Basic EPS improved significantly to βΉ15.76 from βΉ7.87 in the preceding quarter.
πΌ Action for Investors
The strong sequential rebound in profitability and cooling credit costs suggest the worst of the asset quality stress may be subsiding. Investors should maintain a watch on the collection efficiency and the long-term impact of the newly notified Labour Codes on operating expenses.
CreditAccess Grameen Q3 PAT Surges 153% YoY to βΉ252 Cr; Asset Quality Improves
CreditAccess Grameen reported a strong recovery in Q3 FY26 with PAT doubling sequentially to INR 252.1 crore, driven by a 54.4% YoY reduction in credit costs. Asset quality showed significant improvement as PAR 0+ dropped to 4.4% and collection efficiency rose to 95.5% in December 2025. The company's AUM grew 7.1% YoY to INR 26,566 crore, supported by a 13.4% increase in disbursements. Management highlighted a sharp decline in new PAR accretion, particularly in Karnataka, signaling a return to historical stability.
Key Highlights
PAT surged 153.3% YoY and 100.4% QoQ to INR 252.1 crore, with RoA improving to 3.5%
Asset quality improved with PAR 0+ at 4.4% vs 4.7% QoQ and GNPA/NNPA at 4.04%/1.36%
AUM reached INR 26,566 crore (up 7.1% YoY) with disbursements growing 13.4% YoY to INR 5,767 crore
Added 2.06 lakh new borrowers in Q3, with 39% being New-to-Credit (NTC)
Strong capital position with CRAR at 26.4% and liquidity of INR 2,397.4 crore
πΌ Action for Investors
Investors should view the sharp recovery in profitability and stabilizing asset quality as a positive sign of the MFI cycle bottoming out. Monitor the sustainability of collection efficiency and credit cost reductions in the upcoming quarters.
CreditAccess Grameen Q3 FY26: Adjusted PAT at βΉ266 Cr; Asset Quality Normalizes
CreditAccess Grameen reported a Gross Loan Portfolio (GLP) of βΉ26,566 crore for Q3 FY26, a 7.1% YoY increase, driven by robust disbursements of βΉ5,767 crore. The company demonstrated a strong recovery in asset quality, with monthly PAR 15+ accretion dropping to 0.18% in December 2025 from 0.47% in September. Adjusted PAT reached βΉ266 crore, while credit costs continued their downward trajectory to βΉ343 crore. The firm has successfully aligned with MFI guardrails, significantly reducing exposure to over-leveraged borrowers.
Key Highlights
Gross Loan Portfolio (GLP) reached βΉ26,566 crore, up 7.1% YoY, with Retail Finance share increasing to 14.1%.
Monthly PAR 15+ accretion improved significantly to 0.18% in Dec-25 compared to 0.47% in Sep-25.
Quarterly credit costs declined to βΉ343 crore from βΉ526 crore in Q2 FY26, marking a normalization trend.
Adjusted Return on Assets (ROA) stood at 3.7% and Adjusted Return on Equity (ROE) at 14.6% for the quarter.
Exposure to borrowers with >3 lenders reduced drastically to 4.9% of GLP from 25.3% in August 2024.
πΌ Action for Investors
The significant reduction in incremental stress (PAR accretion) and credit costs indicates a turnaround in operational performance. Investors may view this as a positive signal for earnings stability heading into FY27.
CreditAccess Grameen Q3 FY26 PAT Doubles Sequentially to βΉ252 Cr; Impairments Decline
CreditAccess Grameen reported a strong recovery in Q3 FY26 with a Standalone Profit After Tax (PAT) of βΉ252.09 crore, a significant jump from βΉ125.81 crore in the previous quarter. This performance marks a major turnaround from the βΉ99.52 crore loss reported in the same quarter last year. The improvement is primarily attributed to a sharp reduction in impairment costs, which fell to βΉ342.57 crore from βΉ525.67 crore in Q2 FY26. Additionally, the board approved the grant of 9,12,500 stock options to employees at an exercise price of βΉ1,344.97.
Key Highlights
Net Profit for Q3 FY26 reached βΉ252.09 crore, up 100.3% from βΉ125.81 crore in Q2 FY26.
Impairment on financial instruments decreased significantly to βΉ342.57 crore compared to βΉ525.67 crore in the previous quarter.
Total Income for the quarter stood at βΉ1,491.31 crore, maintaining stability despite a slight sequential dip from βΉ1,509.02 crore.
Basic Earnings Per Share (EPS) improved to βΉ15.76 for the quarter, doubling from βΉ7.87 in Q2 FY26.
Board approved 9,12,500 ESOPs at an exercise price of βΉ1,344.97, with a 4-year vesting schedule.
πΌ Action for Investors
The significant reduction in credit costs and the sequential doubling of profits suggest a recovery in asset quality; investors should maintain a positive outlook while monitoring the sustainability of lower impairment levels.
CreditAccess Grameen Dec-25 Update: GLP at βΉ26,566 Cr, PAR 15+ Accretion Drops to 0.18%
CreditAccess Grameen reported a recovery in operational metrics for December 2025, with the Gross Loan Portfolio reaching INR 26,566 crore. Disbursements saw a strong 26% month-on-month growth in December, totaling INR 5,805 crore for the third quarter. Asset quality is normalizing, evidenced by the X-Bucket collection efficiency hitting 99.71% and a sharp decline in new PAR 15+ accretion to 0.18%. While PAR 90+ rose slightly to 2.9% due to older slippages, the overall trend suggests a significant reduction in fresh stress across key states like Karnataka.
Key Highlights
Gross Loan Portfolio (GLP) grew to INR 26,566 crore in Dec-25, up from INR 25,904 crore in Sep-25.
Disbursements in Dec-25 rose 26% MoM, with Q3 FY26 total disbursements reaching INR 5,805 crore.
Asset quality improved as PAR 15+ accretion rate fell to 0.18% in Dec-25 compared to 0.54% in Oct-25.
X-Bucket Collection Efficiency reached 99.71% in Dec-25, signaling normalization across geographies.
The company added 2.1 lakh new borrowers in Q3 FY26, bringing the 9M FY26 total to 6.5 lakh.
πΌ Action for Investors
Investors should monitor the stabilization of PAR 90+ in the upcoming full quarterly results to confirm that forward flows have peaked. The strong rebound in disbursements and collection efficiency suggests the company is successfully navigating recent microfinance sector headwinds.
CreditAccess Grameen Wins Income Tax Appeal; βΉ46.03 Crore Demand Deleted
CreditAccess Grameen Limited has received a favorable ruling from the Commissioner of Income-tax (Appeals) regarding a tax dispute for Assessment Year 2022-23. The order, dated December 24, 2025, allows the company's appeal and completely deletes the previously issued demand of βΉ46.03 crore. This resolution effectively removes a significant contingent liability that had been pending since March 2024. The decision by the National Faceless Appeal Centre provides financial clarity and eliminates the risk of a major cash outflow related to this specific tax matter.
Key Highlights
Commissioner of Income-tax (Appeals) allowed the company's appeal on December 24, 2025.
Income tax demand of βΉ46.03 crore for Assessment Year 2022-23 has been deleted.
The original demand order was dated March 18, 2024.
The ruling was issued by the National Faceless Appeal Centre, Income Tax Department.
πΌ Action for Investors
Investors should view this as a positive development that clears a legal hurdle and protects the company's cash flows. No immediate portfolio changes are necessary based on this news alone.
CreditAccess Grameen Allots USD 30 Million Non-Convertible Bonds to BlueOrchard
CreditAccess Grameen has successfully allotted 3,000 USD-denominated Non-Convertible Bonds (NCBs) to BlueOrchard Microfinance Fund on a private placement basis. The total fundraise amounts to USD 30 million with a face value of USD 10,000 per bond. These secured bonds carry a coupon rate of 240 basis points over Term SOFR and have a five-year tenure maturing in December 2030. This move helps the company diversify its funding sources and secure long-term capital for its microfinance operations.
Key Highlights
Allotment of 3,000 USD-denominated Non-Convertible Bonds aggregating to USD 30 million
Single investor participation from BlueOrchard Microfinance Fund via private placement
Coupon rate set at 240 basis points plus Term SOFR, payable semi-annually
Tenure of 5 years with a partial redemption schedule starting from December 2028
Securities to be listed on NSE IFSC Limited (Gift City)
πΌ Action for Investors
Investors should view this as a positive indicator of the company's ability to attract international institutional capital. Monitor the impact of foreign exchange hedging costs on the overall cost of funds.
CreditAccess Grameen to Issue Bonds & Debentures up to βΉ1500 Crore
CreditAccess Grameen Limited's board has approved the issuance of foreign currency bonds and non-convertible debentures on a private placement basis. The fundraising includes various types of bonds and debentures, both listed and unlisted, secured and unsecured. The aggregate limit for the issuance is set at βΉ1500,00,00,000 (βΉ1500 Crore). These securities will be issued in one or more tranches or series, offering flexibility in raising capital from domestic and foreign markets.
Key Highlights
Issuance of foreign currency bonds of various types on a private placement basis.
Issuance of non-convertible debentures up to βΉ1500,00,00,000.
Debentures may be listed on BSE Limited or National Stock Exchange of India Limited.
Bonds are proposed to be listed on NSE IFSC Limited (βNSE IXβ) / India International Exchange (IFSC) Limited (βIndia INXβ).
πΌ Action for Investors
Investors should monitor the terms and conditions of the bond and debenture issuances, including coupon rates and maturity dates, as they become available. Keep an eye on the company's financial performance and how these funds are utilized to support future growth.